Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-27
2005-12-27
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S255030, C514S326000, C514S331000, C544S360000, C544S364000, C544S365000, C546S199000, C546S208000, C546S210000, C546S225000, C546S229000
Reexamination Certificate
active
06979691
ABSTRACT:
Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates and prodrugs thereof,in which E isX is N or CH, W is —NR16R17, —NR16C(═O)R22, —NR16CO2R22, —OR23, or a heteroaryl or heterocyclo group as defined in the specification, and R1through R12, R16, R17, R22, R23, x, y, and z are as defined in the specification, are useful as modulaters of melanocortin receptors, particularly MC-1R and MC-4R.
REFERENCES:
patent: 5492916 (1996-02-01), Morriello et al.
patent: 5559128 (1996-09-01), Chakravarty et al.
patent: 5622973 (1997-04-01), Morriello et al.
patent: 5804578 (1998-09-01), Chakravarty et al.
patent: 5919777 (1999-07-01), Hansen et al.
patent: 5936089 (1999-08-01), Carpino et al.
patent: 6303620 (2001-10-01), Hansen et al.
patent: 6458790 (2002-10-01), Palucki et al.
patent: 2001/0029259 (2001-10-01), Nargund et al.
patent: 2002/0019523 (2002-02-01), Palucki et al.
patent: WO 99/58501 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/15657 (2000-03-01), None
patent: WO 00/44770 (2000-08-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/00654 (2002-01-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/059107 (2002-08-01), None
patent: WO 02/059108 (2002-08-01), None
Baker Botts “In print reach through claims” attoney's practice profile (2002).
Lendaris et al. “Reach through claims . . . ” Intellectual property Update (2004).
Herpin Timothy
Lawrence R. Michael
Macor John
Morton George C.
Poindexter Graham S.
Bristol--Myers Squibb Company
Chang Celia
Rodney Burton
LandOfFree
Compounds useful as modulators of melanocortin receptors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful as modulators of melanocortin receptors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful as modulators of melanocortin receptors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3487648